Telix Pharmaceuticals (TLPPF) News Today $11.35 +2.46 (+27.67%) As of 09/23/2025 01:32 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock TLPPF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Health Check: Clinuvel, Telix shares surge on regulatory breakthroughs in Europe and USSeptember 22 at 12:04 AM | msn.comTelix Pharmaceuticals (TLPPF) Receives a New Rating from CitiSeptember 20, 2025 | theglobeandmail.comTelix Pharmaceuticals shares surge as Citi starts coverage with ‘buy’ ratingSeptember 19, 2025 | msn.comCitigroup Initiates Coverage of Telix Pharmaceuticals Limited - Depositary Receipt (TLX) with Buy RecommendationSeptember 19, 2025 | msn.comTelix Pharmaceuticals leads ASX 200 gains on FDA progressSeptember 10, 2025 | msn.comJ.P. Morgan downgrades Telix Pharmaceuticals (TLPPF) to a HoldSeptember 3, 2025 | theglobeandmail.comTelix Pharmaceuticals (TLPPF) Gets a Buy from WilsonsSeptember 3, 2025 | theglobeandmail.comMorgan Stanley Reaffirms Their Buy Rating on Telix Pharmaceuticals (TLPPF)August 31, 2025 | theglobeandmail.comTelix Pharmaceuticals: Roadblocks Piling Up, But They're Not InsurmountableAugust 29, 2025 | seekingalpha.comUS FDA seeks more information on Telix Pharma's diagnostic drug for kidney cancerAugust 27, 2025 | reuters.comUBS Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)August 23, 2025 | theglobeandmail.comTelix Pharmaceuticals Limited (TLX) Q2 2025 Earnings Call TranscriptAugust 22, 2025 | seekingalpha.comTelix Pharmaceuticals Limited Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - TLXAugust 22, 2025 | tmcnet.comTelix Pharmaceuticals Limited Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – TLXAugust 21, 2025 | businesswire.comTelix Pharmaceuticals Limited (TLPPF) H1 2025 Earnings Call TranscriptAugust 21, 2025 | seekingalpha.comTelix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growthAugust 20, 2025 | finance.yahoo.comTelix Pharmaceuticals Limited's (ASX:TLX) market cap touched AU$6.0b last week, benefiting both retail investors who own 53% as well as institutionsAugust 18, 2025 | finance.yahoo.comJarden Sticks to Its Buy Rating for Telix Pharmaceuticals (TLPPF)August 11, 2025 | theglobeandmail.comJefferies Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)August 10, 2025 | theglobeandmail.comJ.P. Morgan Remains a Buy on Telix Pharmaceuticals (TLPPF)August 10, 2025 | theglobeandmail.comTelix to Host Webcast on H1 2025 Financial ResultsJuly 30, 2025 | msn.comTelix Pharmaceuticals Limited (TLPPF) - Yahoo FinanceJuly 25, 2025 | finance.yahoo.comBell Potter Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)July 24, 2025 | theglobeandmail.comTelix Reports $204M Revenue, Up 63% YOYJuly 22, 2025 | markets.businessinsider.comTelix Pharmaceuticals (TLPPF) Receives a Buy from UBSJune 14, 2025 | theglobeandmail.comTelix Pharmaceuticals Hosts Investor Day in New York CityJune 11, 2025 | tipranks.comTelix Pharmaceuticals Issues New Share Appreciation RightsJune 4, 2025 | tipranks.comTelix Pharmaceuticals Issues New Equity Securities for Employee IncentivesJune 4, 2025 | tipranks.comTelix Pharmaceuticals to Quote New Securities on ASXJune 4, 2025 | tipranks.comTelix Pharmaceuticals Expands Global Product ApprovalsMay 20, 2025 | tipranks.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowMay 18, 2025 | tipranks.comTelix Pharmaceuticals Expands Market Presence with New Securities QuotationMay 16, 2025 | tipranks.comIs Telix Pharmaceuticals Limited (TLX) the Best Australian Stock to Buy According to Analysts?May 15, 2025 | msn.comTelix Pharmeceuticals: Imaging Biomarkers Paving The Way For TheranosticsMay 13, 2025 | seekingalpha.comTelix Pharmaceuticals Issues Unquoted Share Rights to EmployeesMay 8, 2025 | tipranks.comTelix Pharmaceuticals Expands ASX Quotation with New SecuritiesMay 5, 2025 | tipranks.comAnalysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and Alnylam Pharma (ALNY)April 30, 2025 | theglobeandmail.comUBS Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)April 30, 2025 | theglobeandmail.comTelix Pharmaceuticals Ltd. (TLPPF) Receives a Buy from UBSApril 24, 2025 | markets.businessinsider.comBell Potter Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)April 24, 2025 | markets.businessinsider.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowApril 23, 2025 | tipranks.comTelix Pharmaceuticals Reports Promising Results for TLX101 Glioma TherapyApril 15, 2025 | tipranks.comUBS Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)April 8, 2025 | markets.businessinsider.comTelix Pharmaceuticals gets new technology chiefApril 7, 2025 | msn.comTelix Pharmaceuticals Unaffected by U.S. Trade Tariffs and Chinese Export ControlsApril 6, 2025 | tipranks.comTelix Pharmaceuticals: Building A Radiopharma PowerhouseApril 5, 2025 | seekingalpha.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowApril 2, 2025 | tipranks.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowApril 2, 2025 | tipranks.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowApril 1, 2025 | tipranks.comWilsons Sticks to Its Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)March 25, 2025 | markets.businessinsider.com Get Telix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPPF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TLPPF Media Mentions By Week TLPPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLPPF News Sentiment▼0.180.71▲Average Medical News Sentiment TLPPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLPPF Articles This Week▼41▲TLPPF Articles Average Week Get the Latest News and Ratings for TLPPF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Telix Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 60 Degrees Pharmaceuticals News Today Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Ascentage Pharma Group International News Today Ascletis Pharma News Today Avacta Group News Today Awakn Life Sciences News Today BerGenBio ASA News Today BriaCell Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:TLPPF) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLPPF Stock Alerts